| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
8,876 |
6,253 |
$356K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
9,450 |
6,745 |
$312K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
5,466 |
4,733 |
$206K |
| S8301 |
Infection control supplies, not otherwise specified |
6,739 |
4,655 |
$181K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
12,998 |
5,759 |
$169K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
7,169 |
6,339 |
$94K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
6,653 |
5,876 |
$40K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
467 |
436 |
$34K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
372 |
341 |
$29K |
| 99000 |
|
2,260 |
2,099 |
$21K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
245 |
237 |
$19K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
1,441 |
572 |
$13K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
774 |
748 |
$10K |
| 92558 |
|
1,534 |
1,454 |
$7K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
314 |
285 |
$4K |
| 90461 |
|
347 |
301 |
$3K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
41 |
40 |
$3K |
| 81003 |
|
1,383 |
1,324 |
$2K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
29 |
28 |
$2K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
272 |
202 |
$2K |
| 96161 |
|
365 |
356 |
$614.12 |
| 92550 |
|
25 |
24 |
$361.49 |
| 99050 |
|
19 |
19 |
$261.32 |
| 83655 |
|
26 |
25 |
$257.02 |
| 93000 |
|
15 |
15 |
$142.77 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
18 |
18 |
$122.40 |
| 82043 |
|
32 |
31 |
$107.45 |
| 82570 |
|
31 |
30 |
$91.83 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
771 |
747 |
$35.37 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
99 |
97 |
$16.16 |
| 36415 |
Collection of venous blood by venipuncture |
189 |
176 |
$6.00 |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
44 |
44 |
$0.00 |
| S0257 |
Counseling and discussion regarding advance directives or end of life care planning and decisions, with patient and/or surrogate (list separately in addition to code for appropriate evaluation and management service) |
14 |
13 |
$0.00 |
| 99497 |
|
14 |
14 |
$0.00 |
| 90670 |
|
69 |
68 |
$0.00 |
| 99072 |
|
171 |
154 |
$0.00 |